Wikipedia

Group-specific antigen

(Redirected from Gag (gene))

Group-specific antigen, or gag, is the polyprotein that contains the core structural proteins of an Ortervirus (except Caulimoviridae). It was named as such because scientists used to believe it was antigenic. Now it is known that it makes up the inner shell, not the envelope exposed outside. It makes up all the structural units of viral conformation and provides supportive framework for mature virion.

All orthoretroviral gag proteins are processed by the protease (PR or pro) into MA (matrix), CA (capsid), NC (nucleocapsid) parts, and sometimes more.[1] If Gag fails to cleave into its subunits, virion fails to mature and remains uninfective.

It comprises part of the gag-onc fusion protein.

Gag in HIV

edit
 
HIV-1 Gag protein homo18-mer, Human immunodeficiency virus 1
 
Gag protein in the structure of the RNA genome of HIV-1
Gag polyprotein
Identifiers
OrganismHIV-1 M:B_HXB2R
Symbolgag
UniProtP04591
Search for
StructuresSwiss-model
DomainsInterPro

Numbering system

edit

By convention, the HIV genome is numbered according to HIV-1 group M subtype B reference strain HXB2.[2]

Transcription and mRNA processing

edit

After a virus enters a target cell, the viral genome is integrated into the host cell chromatin. RNA polymerase II then transcribes the 9181 nucleotide full-length viral RNA. HIV Gag protein is encoded by the HIV gag gene, HXB2 nucleotides 790-2292.[2]

MA

edit

The HIV p17 matrix protein (MA) is a 17 kDa protein, of 132 amino acids, which comprises the N-terminus of the Gag polyprotein. It is responsible for targeting Gag polyprotein to the plasma membrane via interaction with PI(4,5)P2 through its highly basic region (HBR).[3] HIV MA also makes contacts with the HIV trans-membrane glycoprotein gp41 in the assembled virus and, indeed, may have a critical role in recruiting Env glycoproteins to viral budding sites.[citation needed]

Once Gag is translated on ribosomes, Gag polyproteins are myristoylated at their N-terminal glycine residues by N-myristoyltransferase 1. This is a critical modification for plasma membrane targeting. In the membrane-unbound form, the MA myristoyl fatty acid tail is sequestered in a hydrophobic pocket in the core of the MA protein.[3]

Recognition of plasma membrane PI(4,5)P2 by the MA HBR activates the "myristoyl switch", wherein the myristoyl group is extruded from its hydrophobic pocket in MA and embedded in the plasma membrane.[3] In parallel to (or possibly concomitant with) myristoyl switch activation, the arachidonic acid moiety of PI(4,5)P2 is extracted from the plasma membrane and binds in a channel on the surface of MA (which is distinct from that previously occupied by the MA myristoyl group.[3] HIV Gag is then tightly bound to the membrane surface via three interactions: 1) that between the MA HBR and the PI(4,5)P2 inositol phosphate, 2) that between the extruded myristoyl tail of MA and the hydrophobic interior of the plasma membrane, and 3) that between the PI(4,5)P2 arachidonic acid moiety and the hydrophobic channel along the MA surface.[citation needed]

CA

edit

The p24 capsid protein (CA) is a 24 kDa protein fused to the C-terminus of MA in the unprocessed HIV Gag polyprotein. After viral maturation, CA forms the viral capsid. CA has two generally recognized domains, the C-terminal domain (CTD) and the N-terminal domain (NTD). The CA CTD and NTD have distinct roles during HIV budding and capsid structure.[citation needed]

When a Western blot test is used to detect HIV infection, p24 is one of the three major proteins tested for, along with gp120/gp160 and gp41.

While MA, IN, VPR, and cPPT had been previously implicated as factors in HIV's ability to target non-dividing cells, CA has been shown to be the dominant determinant of retrovirus infectivity in non-dividing cells, which is key in helping to avoid insertional mutagenesis in lentiviral gene therapy. [4]

SP1

edit

Spacer peptide 1 (SP1, previously 'p2') is a 14-amino acid polypeptide intervening between CA and NC. Cleavage of the CA-SP1 junction is the final step in viral maturation, which allows CA to condense into the viral capsid. SP1 is unstructured in solution but, in the presence of less polar solvents or at high polypeptide concentrations, it adopts an α-helical structure.[5] In scientific research, western blots for CA (24 kDa) can indicate a maturation defect by the high relative presence of a 25 kDa band (uncleaved CA-SP1). SP1 plays a critical role in HIV particle assembly,[5] although the exact nature of its role and the physiological relevance of SP1 structural dynamics are unknown.

NC

edit

The HIV nucleocapsid protein (NC) is a 7 kDa zinc finger protein in the Gag polyprotein and which, after viral maturation, forms the viral nucleocapsid. NC recruits full-length viral genomic RNA to nascent virions.[citation needed]

SP2

edit

Spacer peptide 2 (SP2, previously 'p1') is a 16-amino acid polypeptide of unknown function which separates Gag proteins NC and p6.

p6

edit

HIV p6 is a 6 kDa polypeptide at the C-terminus of the Gag polyprotein.[6] It recruits cellular proteins TSG101 (a component of ESCRT-I) and ALIX to initiate virus particle budding from the plasma membrane. p6 has no known function in the mature virus.[citation needed]

In endogenous retroviruses

edit

Both Human endogenous retrovirus K and Human Endogenous Retrovirus-W copies carry gag genes, usually damaged, that are expressed widely. There is a long history of speculating their involvement in multiple sclerosis and other neurological disorders.[7]

In other viruses

edit
Spumavirus gag protein
Identifiers
SymbolGag_spuma
PfamPF03276
InterProIPR004957
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

The gag gene of Spumaretrovirinae (e.g. P14349) and Metaviridae (e.g. Q86TG7) only have a recognizable nucleocapsid part. It also lacks a myristoylation sequence.[8]

The Spumaretroviral (SV) gag is related to orthoretrovieral gag, as structural work has shown that part of the N-terminal domain shares functional and structural homology with the typical capsid protein.[9] The SV gag is not processed like the orthoretrovieral gag; only a tiny 3kDa cut at the C-terminal is required, and other cleavage sites are generally inefficient.[10]

The Metaviral (MV, Ty3/gypsy) gag, too, is known to have a structurally homologous capsid protein. Each capsid is assembled from 540 proteins. Unlike orthoretroviral CA proteins, it does not require dramatic maturation.[11] The animal Activity-regulated cytoskeleton-associated protein (ARC) gene is repurposed from the metaviral gag.[12] This gene is responsible for transporting mRNA among neural cells, a key part of neuroplasticity. It has independently arose in Tetrapoda and Drosophila.[13]

Caulimoviridae members rarely get a gag assignment to its capsid-containing ORF, but the CP-PRO-POL layout does show analogy with the canonical gag-pol setup. Whether the parts stick together into a polyprotein depends on the genus.[citation needed]

See also

edit

References

edit
  1. ^ Coffin JM, Hughes SH, Varmus HE (1997). "Genetic Organization". Retroviruses. Cold Spring Harbor Laboratory Press.
  2. ^ a b "Landmarks of the HIV genome". Los Alamos National Laboratory. Retrieved 2013-11-04.
  3. ^ a b c d Lalonde MS, Sundquist WI (November 2012). "How HIV finds the door". Proceedings of the National Academy of Sciences of the United States of America. 109 (46): 18631–2. Bibcode:2012PNAS..10918631L. doi:10.1073/pnas.1215940109. PMC 3503163. PMID 23118338.
  4. ^ Yamashita M, Emerman M (June 2004). "Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells". Journal of Virology. 78 (11): 5670–5678. doi:10.1128/JVI.78.11.5670-5678.2004. PMC 415837. PMID 15140964.
  5. ^ a b Datta SA, Temeselew LG, Crist RM, Soheilian F, Kamata A, Mirro J, et al. (May 2011). "On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch?". Journal of Virology. 85 (9): 4111–21. doi:10.1128/JVI.00006-11. PMC 3126284. PMID 21325421.
  6. ^ Solbak SM, Reksten TR, Hahn F, Wray V, Henklein P, Henklein P, et al. (February 2013). "HIV-1 p6 - a structured to flexible multifunctional membrane-interacting protein". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1828 (2). Elsevier BV: 816–23. doi:10.1016/j.bbamem.2012.11.010. PMID 23174350.
  7. ^ Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C (February 2011). "Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812 (2): 162–76. doi:10.1016/j.bbadis.2010.07.016. PMC 7172332. PMID 20696240.
  8. ^ Touret F, Guiguen F, Greenland T, Terzian C (December 2014). "In between: gypsy in Drosophila melanogaster reveals new insights into endogenous retrovirus evolution". Viruses. 6 (12): 4914–25. doi:10.3390/v6124914. PMC 4276936. PMID 25502325.
  9. ^ Ball NJ, Nicastro G, Dutta M, Pollard DJ, Goldstone DC, Sanz-Ramos M, et al. (November 2016). "Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid". PLOS Pathogens. 12 (11): e1005981. doi:10.1371/journal.ppat.1005981. PMC 5102385. PMID 27829070.
  10. ^ Müllers E (March 2013). "The foamy virus Gag proteins: what makes them different?". Viruses. 5 (4): 1023–41. doi:10.3390/v5041023. PMC 3705263. PMID 23531622.
  11. ^ Dodonova SO, Prinz S, Bilanchone V, Sandmeyer S, Briggs JA (May 2019). "Structure of the Ty3/Gypsy retrotransposon capsid and the evolution of retroviruses". Proceedings of the National Academy of Sciences of the United States of America. 116 (20): 10048–10057. doi:10.1073/pnas.1900931116. PMC 6525542. PMID 31036670.
  12. ^ Cottee MA, Letham SC, Young GR, Stoye JP, Taylor IA (January 2020). "Drosophila melanogaster ARC1 reveals a repurposed molecule with characteristics of retroviral Gag". Science Advances. 6 (1): eaay6354. doi:10.1126/sciadv.aay6354. PMC 6938703. PMID 31911950.
  13. ^ Parrish NF, Tomonaga K (January 2018). "A Viral (Arc)hive for Metazoan Memory". Cell. 172 (1–2): 8–10. doi:10.1016/j.cell.2017.12.029. PMID 29328922.
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=Group-specific_antigen&oldid=1169472038"